These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 28322445

  • 1. Transplantation of mesenchymal stem cells overexpressing IL10 attenuates cardiac impairments in rats with myocardial infarction.
    Meng X, Li J, Yu M, Yang J, Zheng M, Zhang J, Sun C, Liang H, Liu L.
    J Cell Physiol; 2018 Jan; 233(1):587-595. PubMed ID: 28322445
    [Abstract] [Full Text] [Related]

  • 2. Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction.
    Chen L, Zhang Y, Tao L, Yang Z, Wang L.
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):9-18. PubMed ID: 27913896
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
    Chen Y, Zhao Y, Chen W, Xie L, Zhao ZA, Yang J, Chen Y, Lei W, Shen Z.
    Stem Cell Res Ther; 2017 Nov 25; 8(1):268. PubMed ID: 29178928
    [Abstract] [Full Text] [Related]

  • 4. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
    Huang J, Zhang Z, Guo J, Ni A, Deb A, Zhang L, Mirotsou M, Pratt RE, Dzau VJ.
    Circ Res; 2010 Jun 11; 106(11):1753-62. PubMed ID: 20378860
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Catalpol Promotes the Survival and VEGF Secretion of Bone Marrow-Derived Stem Cells and Their Role in Myocardial Repair After Myocardial Infarction in Rats.
    Ju X, Xue D, Wang T, Ge B, Zhang Y, Li Z.
    Cardiovasc Toxicol; 2018 Oct 11; 18(5):471-481. PubMed ID: 29752623
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC, Selvaraju V, Thirunavukkarasu M, Goldman JW, Husain A, Alexander Palesty J, Sanchez JA, McFadden DW, Maulik N.
    Int J Cardiol; 2015 Dec 15; 201():517-28. PubMed ID: 26322599
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction.
    Zhao X, Zhang W, Xing D, Li P, Fu J, Gong K, Hage FG, Oparil S, Chen YF.
    Am J Physiol Heart Circ Physiol; 2013 Aug 15; 305(4):H590-8. PubMed ID: 23771691
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction.
    Hu X, Wang J, Chen J, Luo R, He A, Xie X, Li J.
    Eur J Cardiothorac Surg; 2007 Mar 15; 31(3):438-43. PubMed ID: 17239611
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
    Zhang Z, Liang D, Gao X, Zhao C, Qin X, Xu Y, Su T, Sun D, Li W, Wang H, Liu B, Cao F.
    Basic Res Cardiol; 2014 Jul 15; 109(4):417. PubMed ID: 24847908
    [Abstract] [Full Text] [Related]

  • 17. Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival.
    Li H, Zuo S, He Z, Yang Y, Pasha Z, Wang Y, Xu M.
    Am J Physiol Heart Circ Physiol; 2010 Dec 15; 299(6):H1772-81. PubMed ID: 20870802
    [Abstract] [Full Text] [Related]

  • 18. Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction.
    Song YS, Joo HW, Park IH, Shen GY, Lee Y, Shin JH, Kim H, Kim KS.
    PLoS One; 2017 Dec 15; 12(6):e0179972. PubMed ID: 28662151
    [Abstract] [Full Text] [Related]

  • 19. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F, Zhu X, Hu XQ, Fang ZF, Tang L, Lu XL, Zhou SH.
    Int J Mol Med; 2013 Feb 15; 31(2):484-92. PubMed ID: 23229021
    [Abstract] [Full Text] [Related]

  • 20. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
    Zhao L, Liu X, Zhang Y, Liang X, Ding Y, Xu Y, Fang Z, Zhang F.
    Exp Cell Res; 2016 May 15; 344(1):30-39. PubMed ID: 27025401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.